Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

(2020) Tine Iskov Kopp et al.   ANNALS OF THE RHEUMATIC DISEASES

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events

(2020) Amy Kunchok et al.   JAMA Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

(2017) Marta Pérez-De-Lis et al.   Expert Opinion On Drug Safety

Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation

(2017) Michelle L. Degelman et al.   Multiple Sclerosis and Related Disorders

Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis

(2013) Ruth Dobson et al.   JOURNAL OF NEUROLOGY

Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database

(2013) I. S. Mackenzie et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

(2012) Adam P. Gregory et al.   NATURE

Monoclonal antibody therapy-associated neurological disorders

(2011) Xavier Bosch et al.   Nature Reviews Neurology

Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment

(2011) Leann Maska et al.   ARTHRITIS CARE & RESEARCH